AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
RITUXIMAB in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MABTHERA Solution for subcutaneous injection | Rwanda FDA-HMP-MA-2045 | F. HOFFMANN-LA ROCHE AG WURMISWEG | active | 29 Sept 2029 |
RITUXIMAB — RDA Registration Details
RDA (Rwanda) has 1 registered product containing RITUXIMAB, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.